Aoife Corrigan
Aoife Corrigan is currently a QA Consultant for Eli Lilly, Kinsale. Aoife received a Ph.D degree in Organic Synthetic Chemistry from Southampton University in 1997. Prior to receiving her Ph.D she obtained a Bachelor of Science Degree from University College, Dublin, and worked at Glaxo as a Medicinal Chemist.
Aoife has worked in Eli Lilly for 20 years where she has held a number of positions both in Technical Services and Quality. In recent years, she has been actively involved in development of Lilly quality systems and operating principles for small volume continuous manufacturing and PAT implementation in addition to supporting new product introduction including registration for batch and hybrid continuous processes. She provides quality consultation, direction and support for small molecule development and commercial manufacturing in areas such tech transfers, NPIs, continuous manufacturing, material tracking and RTD models, lifecycle management of models, PAT-DMS, process validation & lifecycle approach and emerging technologies. Aoife continues to ensure that the quality systems for continuous manufacturing and PAT remain compliant with emerging regulatory standards and guidelines.
Aoife has worked in Eli Lilly for 20 years where she has held a number of positions both in Technical Services and Quality. In recent years, she has been actively involved in development of Lilly quality systems and operating principles for small volume continuous manufacturing and PAT implementation in addition to supporting new product introduction including registration for batch and hybrid continuous processes. She provides quality consultation, direction and support for small molecule development and commercial manufacturing in areas such tech transfers, NPIs, continuous manufacturing, material tracking and RTD models, lifecycle management of models, PAT-DMS, process validation & lifecycle approach and emerging technologies. Aoife continues to ensure that the quality systems for continuous manufacturing and PAT remain compliant with emerging regulatory standards and guidelines.